A Prospective Study of CD38/45 Flow Cytometry and Immunofluorescence Microscopy to Detect Blood Plasma Cells in Patients with Plasma Cell Proliferative Disorders
暂无分享,去创建一个
[1] H. Goldschmidt,et al. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation , 1999, Bone Marrow Transplantation.
[2] S. Barrans,et al. Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression , 1999, British journal of haematology.
[3] H. Goldschmidt,et al. Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone. , 1998, Experimental hematology.
[4] A. Morley,et al. Longitudinal analysis of circulating myeloma cells detected by allele specific mRNA in situ hybridization , 1998, American journal of hematology.
[5] F. Prósper,et al. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement , 1997, Leukemia.
[6] G. Morgan,et al. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage , 1997, British journal of haematology.
[7] D. Huhn,et al. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen , 1997, British journal of haematology.
[8] M. Litzow,et al. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation , 1997, Bone Marrow Transplantation.
[9] W. O'Fallon,et al. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. , 1996, Blood.
[10] R. Kyle,et al. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. , 1996, Blood.
[11] G. Ahmann,et al. Detection of myeloma cells in the peripheral blood by flow cytometry. , 1996, Cytometry.
[12] A. Kuramoto,et al. Identification of early plasma cells in peripheral blood and their clinical significance , 1996, British journal of haematology.
[13] W. O'Fallon,et al. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myeloma , 1994, British journal of haematology.
[14] M. Dhodapkar,et al. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma , 1993, Cancer.
[15] J. Katzmann,et al. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] A. Palumbo,et al. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] L. Pilarski,et al. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. , 1998, Blood.
[18] R. Kyle,et al. Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? , 1995, Leukemia & lymphoma.